![Snehal Shah](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Snehal Shah
Direttore Tecnico/Scientifico/R&S presso OCULIS HOLDING AG
Profilo
Snehal Shah is currently the President-Research & Development at Oculis Holding AG.
Previously, Dr. Shah worked as a Member-Hisamitsu Group at Noven Pharmaceuticals, Inc. from 2012 to 2017.
Dr. Shah also held the position of SVP, Chief Regulatory & Product Strategy Officer at IVERIC bio, Inc. Dr. Shah holds a doctorate degree from the University of Kansas and an undergraduate degree from Rutgers University- Newark.
Posizioni attive di Snehal Shah
Società | Posizione | Inizio |
---|---|---|
OCULIS HOLDING AG | Direttore Tecnico/Scientifico/R&S | 10/04/2024 |
Precedenti posizioni note di Snehal Shah
Società | Posizione | Fine |
---|---|---|
Noven Pharmaceuticals, Inc.
![]() Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Corporate Officer/Principal | 01/01/2017 |
IVERIC BIO, INC. | Consigliere Generale | - |
Formazione di Snehal Shah
Rutgers University- Newark | Undergraduate Degree |
University of Kansas | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
OCULIS HOLDING AG | Health Technology |
Aziende private | 2 |
---|---|
IVERIC bio, Inc.
![]() IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Noven Pharmaceuticals, Inc.
![]() Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
- Borsa valori
- Insiders
- Snehal Shah